Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

Share Price is delayed by 15 minutes
Get Live Data
1,095.00    25.00 (2.34%)
Bid:
1,075.00
Ask:
1,095.00
Spread: 20.00 (1.86%)
Market Cap: £348.51m
IBT Live PriceLast checked at - London Stock Exchange

Intraday Int.biotech. Share Chart

Latest Factsheet and Blog

21 Jul 2025 10:00

RNS Number : 8645R
Intl. Biotechnology Trust PLC
21 July 2025
Β 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Β 

Latest Factsheet and Blog

Β 

IBT's factsheet for the month ended 30 June 2025 is now available directly via its web page. Please click here, then 'latest factsheet'.

Β 

Following up on our recent article,Β Things are grim, but science will prevail, we wanted to provide a further update on what recent political developments in the US might mean for biotech investors. While many of the details are still being worked through, two issues - drug pricing reform and potential tariffs - continue to result in an unusual degree of uncertainty for the sector. In this note, we explore those concerns in more detail, explain how they're affecting sentiment, and set out why we believe the long-term investment case for biotech remains intact.

Β 

The blog can be read here:

Β 

https://www.schroders.com/en-gb/uk/individual/content/making-sense-of-a-shifting-policy-landscape/

Β 

To sign up for IBT updates by email, please click here.

Β 

Β 

ENDS

Β 

Β 

Enquiries:

Β 

Schroder Investment Management Limited

Β 

Kirsty Preston (PR)

Β 

Natalia de Sousa

Β 

Β 

020 7658 6000

Β 

020 7658 6000

Β 

Β 

Kaso Legg Communications (Financial PR)

Β 

Charles Gorman

Henry Taylor

Effie Aye Maung Hider

Β 

Β 

IBT@kl-communications.com

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAVFLBLEDLEBBV
Date   Source Headline
30th Jun 202611:38 amRNSNet Asset Value(s)
29th Jun 202611:41 amRNSNet Asset Value(s)
26th Jun 202611:35 amRNSNet Asset Value(s)
25th Jun 202611:48 amRNSNet Asset Value(s)
24th Jun 202611:10 amRNSNet Asset Value(s)
23rd Jun 202611:40 amRNSNet Asset Value(s)
22nd Jun 20263:35 pmRNS-RPortfolio company Apogee to be acquired by AbbVie
22nd Jun 202611:27 amRNSNet Asset Value(s)
19th Jun 202611:16 amRNSNet Asset Value(s)
18th Jun 202611:00 amRNSNet Asset Value(s)
17th Jun 202611:08 amRNSNet Asset Value(s)
16th Jun 202611:37 amRNSNet Asset Value(s)
15th Jun 202611:43 amRNSNet Asset Value(s)
12th Jun 202611:21 amRNSNet Asset Value(s)
11th Jun 202611:05 amRNSNet Asset Value(s)
10th Jun 202611:42 amRNSNet Asset Value(s)
9th Jun 20261:11 pmRNS-RGSK to acquire IBT portfolio company Nuvalent
9th Jun 202611:47 amRNSNet Asset Value(s)
8th Jun 202611:50 amRNSNet Asset Value(s)
5th Jun 202611:36 amRNSNet Asset Value(s)
4th Jun 202611:33 amRNSNet Asset Value(s)
3rd Jun 202611:16 amRNSNet Asset Value(s)
2nd Jun 202612:01 pmRNSNet Asset Value(s)
1st Jun 202611:48 amRNSNet Asset Value(s)
29th May 202611:33 amRNSNet Asset Value(s)
28th May 202611:37 amRNSNet Asset Value(s)
27th May 202611:26 amRNSNet Asset Value(s)
26th May 202611:55 amRNSNet Asset Value(s)
22nd May 202611:33 amRNSNet Asset Value(s)
21st May 202610:57 amRNSNet Asset Value(s)
20th May 202611:31 amRNSNet Asset Value(s)
19th May 202611:35 amRNSNet Asset Value(s)
18th May 202611:36 amRNSNet Asset Value(s)
15th May 202611:45 amRNSNet Asset Value(s)
14th May 202611:45 amRNSNet Asset Value(s)
13th May 202611:35 amRNSNet Asset Value(s)
13th May 20267:00 amRNS-RResults analysis from Kepler Trust Intelligence
12th May 202611:11 amRNSNet Asset Value(s)
12th May 20267:00 amRNSHalf-year Report
11th May 202611:50 amRNSNet Asset Value(s)
8th May 202611:50 amRNSNet Asset Value(s)
7th May 202611:50 amRNSNet Asset Value(s)
6th May 20261:24 pmRNS-RInvestor Presentation via Investor Meet Company
6th May 202611:38 amRNSNet Asset Value(s)
5th May 202611:17 amRNSNet Asset Value(s)
1st May 202611:55 amRNSNet Asset Value(s)
1st May 202611:23 amRNSTotal Voting Rights
30th Apr 202611:45 amRNSNet Asset Value(s)
29th Apr 20263:25 pmRNS-RPortfolio company KalVista acquired by Chiesi
29th Apr 202610:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.